Results 231 to 240 of about 9,342 (307)

Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments

International Journal of Biological Macromolecules, 2020
Md Rizwanullah, Sultan Alshehri, Syed Sarim Imam   +2 more
exaly   +2 more sources

Efficacy of perioperative 2% dorzolamide ophthalmic solution for reduction of postoperative ocular hypertension in dogs following routine phacoemulsification surgery: A prospective clinical trial.

Veterinary Ophthalmology, 2023
OBJECTIVE To evaluate the efficacy of 2% dorzolamide ophthalmic solution for reduction of postoperative ocular hypertension (POH) following routine phacoemulsification surgery in dogs.
Andrew C Lewin, Jennifer Hu, Chin-Chi Liu, P. Camacho, R. Carter   +4 more
semanticscholar   +1 more source

Induced Corneal Ulcers in Cats - Effects of 2% Dorzolamide on Epithelization Time and on the Expression of Matrix Metalloproteinase-9

Acta Scientiae Veterinariae, 2023
Background: Topically administered 2% dorzolamide is among the most commonly used agents to lower IOP. As a complication of glaucoma, blind patients may develop corneal ulcers secondary to trauma.
Fábio Dumit Pizzinatto, A. Ribeiro, Bruna Carvalho Silveira, Paloma Moraes Lobo, Hanna Rodrigues Miranda, Nathalia Assis Pereira   +5 more
semanticscholar   +1 more source

Adverse analytical finding due to red blood cells transfusion: A rare case involving the diuretic dorzolamide.

Drug Testing and Analysis, 2022
Early November 2020 an Olympic gold medal winner returned during an out-competition control an adverse analytical finding for dorzolamide, a diuretic mostly used to treat glaucoma.
P. Kintz, L. Gheddar, J. Raul
semanticscholar   +1 more source

Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation

International Journal of Pharmaceutics, 2019
Giselle Foureaux, Leonardo L Fuscaldi, Simone Odilia Antunes Fernandes   +2 more
exaly   +2 more sources

Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation

AAPS PharmSciTech, 2019
Dorzolamide HCl (DRZ) ophthalmic drop is one of the most common glaucoma medications which rapidly eliminates after instillation leading to short residence time of the drug on cornea.
Maryam Kouchak
exaly   +2 more sources

Optical Coherence Tomography Angiography Vessel Density Changes in Normal-tension Glaucoma Treated With Carteolol, Brimonidine, or Dorzolamide

Journal of glaucoma, 2021
Supplemental Digital Content is available in the text. Precis: In patients with normal-tension glaucoma (NTG), topical dorzolamide might enhance the vessel density (VD), topical carteolol decreased the VD in the inferior-temporal peripapillary retina ...
Yun-Hsuan Lin, W. Su, Shih-Ming Huang, L. Chuang, Lung-Chien Chen   +4 more
semanticscholar   +1 more source